Thomas Niel

Thomas Niel

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

7 Penny Stocks That Could Have an Explosive Year-End

While meme trends are on the wane, these seven penny stocks still stand to make turbocharged moves higher in the short-term.

The Novavax Rebound Is Just Warming Up

Still likely to see high volatility, if you can't handle the wild swings you may want to look elsewhere. But if you're looking for a vaccine play where the upside potential is crystal clear? NVAX remains your best choice.

Wait for Opportune Weakness Before Buying Sundial Growers

At some point down the road, SNDL stock could fall to a more opportune entry point. Unfortunately, though, now is not that time.

Many Factors Could Still Sink Palantir Stock

As Palantir's risk continues to vastly exceed its near-term potential gains, steering clear of PLTR stock remains your best move.

Another Spike for Shiba Inu Seems Unlikely, But Possible

With its run-up in price unprecedented, and its next move tough to predict? The best approach with Shiba Inu remains the same. Only invest what you can afford to lose into it.